The role of microRNAs in glioma initiation and progression

Frontiers in Bioscience

Volumn 17, Issue 2, 2012, Pages 700-712

  Zhang, Ying ^a   Dutta, Anindya ^b   Abounader, Roger ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Departments of Biochemistry   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Glioblastoma; Glioma; microRNA; Review; Stem Cells

Indexed keywords

EID: 84860344943     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3952     Document Type: Article

References (97)

1. V. Ambros and R. C. Lee: Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol, 265, 131-58 (2004)
2. Y. S. Lee and A. Dutta: MicroRNAs in cancer. Annu Rev Pathol, 4, 199-227 (2009)
3. I. Bentwich, A. Avniel, Y. Karov, R. Aharonov, S. Gilad, O. Barad, A. Barzilai, P. Einat, U. Einav, E. Meiri, E. Sharon, Y. Spector and Z. Bentwich: Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet, 37(7), 766-70 (2005) (Pubitemid 41754896)
4. S. Griffiths-Jones, H. K. Saini, S. van Dongen and A. J. Enright: miRBase: tools for microRNA genomics. Nucleic Acids Res, 36(Database issue), D154-8 (2008) (Pubitemid 351149713)
5. S. Griffiths-Jones, R. J. Grocock, S. van Dongen, A. Bateman and A. J. Enright: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res, 34(Database issue), D140-4 (2006)
6. A. Rodriguez, S. Griffiths-Jones, J. L. Ashurst and A. Bradley: Identification of mammalian microRNA host genes and transcription units. Genome Res, 14(10A), 1902-10 (2004) (Pubitemid 39386503)
7. J. Yu, F. Wang, G. H. Yang, F. L. Wang, Y. N. Ma, Z. W. Du and J. W. Zhang: Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem Biophys Res Commun, 349(1), 59-68 (2006) (Pubitemid 44331762)
8. R. Yi, Y. Qin, I. G. Macara and B. R. Cullen: Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev, 17(24), 3011-6 (2003) (Pubitemid 38040764)
9. E. Lund, S. Guttinger, A. Calado, J. E. Dahlberg and U. Kutay: Nuclear export of microRNA precursors. Science, 303(5654), 95-8 (2004) (Pubitemid 38055779)
10. G. Hutvagner, J. McLachlan, A. E. Pasquinelli, E. Balint, T. Tuschl and P. D. Zamore: A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science, 293(5531), 834-8 (2001) (Pubitemid 32743968)
11. W. Filipowicz, S. N. Bhattacharyya and N. Sonenberg: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 9(2), 102-14 (2008)
12. B. P. Lewis, C. B. Burge and D. P. Bartel: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120(1), 15-20 (2005) (Pubitemid 40094598)
13. G. A. Calin and C. M. Croce: MicroRNA signatures in human cancers. Nat Rev Cancer, 6(11), 857-66 (2006) (Pubitemid 44629897)
14. A. Gaur, D. A. Jewell, Y. Liang, D. Ridzon, J. H. Moore, C. Chen, V. R. Ambros and M. A. Israel: Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res, 67(6), 2456-68 (2007) (Pubitemid 46548930)
15. G. A. Calin, C. Sevignani, C. D. Dumitru, T. Hyslop, E. Noch, S. Yendamuri, M. Shimizu, S. Rattan, F. Bullrich, M. Negrini and C. M. Croce: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A, 101(9), 2999-3004 (2004) (Pubitemid 38327724)
16. A. Lujambio, S. Ropero, E. Ballestar, M. F. Fraga, C. Cerrato, F. Setien, S. Casado, A. Suarez-Gauthier, M. Sanchez-Cespedes, A. Git, I. Spiteri, P. P. Das, C. Caldas, E. Miska and M. Esteller: Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res, 67(4), 1424-9 (2007) (Pubitemid 46383366)
17. L. He, X. He, L. P. Lim, E. de Stanchina, Z. Xuan, Y. Liang, W. Xue, L. Zender, J. Magnus, D. Ridzon, A. L. Jackson, P. S. Linsley, C. Chen, S. W. Lowe, M. A. Cleary and G. J. Hannon: A microRNA component of the p53 tumour suppressor network. Nature, 447(7148), 1130-4 (2007) (Pubitemid 47014436)
18. M. Dews, A. Homayouni, D. Yu, D. Murphy, C. Sevignani, E. Wentzel, E. E. Furth, W. M. Lee, G. H. Enders, J. T. Mendell and A. Thomas-Tikhonenko: Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet, 38(9), 1060-5 (2006) (Pubitemid 44325933)
19. Y. Sylvestre, V. De Guire, E. Querido, U. K. Mukhopadhyay, V. Bourdeau, F. Major, G. Ferbeyre and P. Chartrand: An E2F/miR-20a autoregulatory feedback loop. J Biol Chem, 282(4), 2135-43 (2007) (Pubitemid 47076740)
20. J. M. Thomson, M. Newman, J. S. Parker, E. M. Morin-Kensicki, T. Wright and S. M. Hammond: Extensive posttranscriptional regulation of microRNAs and its implications for cancer. Genes Dev, 20(16), 2202-7 (2006)
21. J. Lu, G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B. L. Ebert, R. H. Mak, A. A. Ferrando, J. R. Downing, T. Jacks, H. R. Horvitz and T. R. Golub: MicroRNA expression profiles classify human cancers. Nature, 435(7043), 834-8 (2005) (Pubitemid 40839735)
22. G. A. Calin, C. G. Liu, C. Sevignani, M. Ferracin, N. Felli, C. D. Dumitru, M. Shimizu, A. Cimmino, S. Zupo, M. Dono, M. L. Dell'Aquila, H. Alder, L. Rassenti, T. J. Kipps, F. Bullrich, M. Negrini and C. M. Croce: MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A, 101(32), 11755-60 (2004) (Pubitemid 39095368)
23. G. Hutvagner and P. D. Zamore: A microRNA in a multiple-turnover RNAi enzyme complex. Science, 297(5589), 2056-60 (2002)
24. J. Weiler, J. Hunziker and J. Hall: Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther, 13(6), 496-502 (2006)
25. P. Y. Wen and S. Kesari: Malignant gliomas in adults. N Engl J Med, 359(5), 492-507 (2008)
26. C. G. Hadjipanayis and E. G. Van Meir: Brain cancer propagating cells: biology, genetics and targeted therapies. Trends Mol Med, 15(11), 519-30 (2009)
27. S. K. Singh, C. Hawkins, I. D. Clarke, J. A. Squire, J. Bayani, T. Hide, R. M. Henkelman, M. D. Cusimano and P. B. Dirks: Identification of human brain tumour initiating cells. Nature, 432(7015), 396-401 (2004) (Pubitemid 39551674)
28. R. Galli, E. Binda, U. Orfanelli, B. Cipelletti, A. Gritti, S. De Vitis, R. Fiocco, C. Foroni, F. Dimeco and A. Vescovi: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res, 64(19), 7011-21 (2004) (Pubitemid 39331011)
29. J. Lee, S. Kotliarova, Y. Kotliarov, A. Li, Q. Su, N. M. Donin, S. Pastorino, B. W. Purow, N. Christopher, W. Zhang, J. K. Park and H. A. Fine: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell, 9(5), 391-403 (2006) (Pubitemid 43668737)
30. S. Mazzoleni, L. S. Politi, M. Pala, M. Cominelli, A. Franzin, L. Sergi Sergi, A. Falini, M. De Palma, A. Bulfone, P. L. Poliani and R. Galli: Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res, 70(19), 7500-13 (2010)
31. S. Bao, Q. Wu, R. E. McLendon, Y. Hao, Q. Shi, A. B. Hjelmeland, M. W. Dewhirst, D. D. Bigner and J. N. Rich: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444(7120), 756-60 (2006) (Pubitemid 44949604)
32. M. Dean, T. Fojo and S. Bates: Tumour stem cells and drug resistance. Nat Rev Cancer, 5(4), 275-84 (2005) (Pubitemid 40488633)
33. T. C. Johannessen, J. Wang, K. O. Skaftnesmo, P. O. Sakariassen, P. O. Enger, K. Petersen, A. M. Oyan, K. H. Kalland, R. Bjerkvig and B. B. Tysnes: Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype. Neuropathol Appl Neurobiol, 35(4), 380-93 (2009)
34. G. Liu, X. Yuan, Z. Zeng, P. Tunici, H. Ng, I. R. Abdulkadir, L. Lu, D. Irvin, K. L. Black and J. S. Yu: Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer, 5, 67 (2006)
35. S. Kesari and C. D. Stiles: The bad seed: PDGF receptors link adult neural progenitors to glioma stem cells. Neuron, 51(2), 151-3 (2006) (Pubitemid 44041869)
36. S. G. Piccirillo, B. A. Reynolds, N. Zanetti, G. Lamorte, E. Binda, G. Broggi, H. Brem, A. Olivi, F. Dimeco and A. L. Vescovi: Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumourinitiating cells. Nature, 444(7120), 761-5 (2006) (Pubitemid 44949605)
37. M. M. Sherry, A. Reeves, J. K. Wu and B. H. Cochran: STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells, 27(10), 2383-92 (2009)
38. Y. Zhu, F. Guignard, D. Zhao, L. Liu, D. K. Burns, R. P. Mason, A. Messing and L. F. Parada: Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell, 8(2), 119-30 (2005) (Pubitemid 41132741)
39. E. E. Bar, A. Chaudhry, A. Lin, X. Fan, K. Schreck, W. Matsui, S. Piccirillo, A. L. Vescovi, F. DiMeco, A. Olivi and C. G. Eberhart: Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells, 25(10), 2524-33 (2007) (Pubitemid 47582744)
40. X. Fan, L. Khaki, T. S. Zhu, M. E. Soules, C. E. Talsma, N. Gul, C. Koh, J. Zhang, Y. M. Li, J. Maciaczyk, G. Nikkhah, F. Dimeco, S. Piccirillo, A. L. Vescovi and C. G. Eberhart: NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells, 28(1), 5-16 (2010)
41. H. Zheng, H. Ying, H. Yan, A. C. Kimmelman, D. J. Hiller, A. J. Chen, S. R. Perry, G. Tonon, G. C. Chu, Z. Ding, J. M. Stommel, K. L. Dunn, R. Wiedemeyer, M. J. You, C. Brennan, Y. A. Wang, K. L. Ligon, W. H. Wong, L. Chin and R. A. DePinho: p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature, 455(7216), 1129-33 (2008)
42. A. Conti, M. Aguennouz, D. La Torre, C. Tomasello, S. Cardali, F. F. Angileri, F. Maio, A. Cama, A. Germano, G. Vita and F. Tomasello: miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J Neurooncol, 93(3), 325-32 (2009)
43. J. A. Chan, A. M. Krichevsky and K. S. Kosik: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res, 65(14), 6029-33 (2005) (Pubitemid 40994386)
44. J. Silber, D. A. Lim, C. Petritsch, A. I. Persson, A. K. Maunakea, M. Yu, S. R. Vandenberg, D. G. Ginzinger, C. D. James, J. F. Costello, G. Bergers, W. A. Weiss, A. Alvarez-Buylla and J. G. Hodgson: miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med, 6, 14 (2008)
45. G. Gabriely, T. Wurdinger, S. Kesari, C. C. Esau, J. Burchard, P. S. Linsley and A. M. Krichevsky: MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol, 28(17), 5369-80 (2008)
46. B. Malzkorn, M. Wolter, F. Liesenberg, M. Grzendowski, K. Stuhler, H. E. Meyer and G. Reifenberger: Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol, 20(3), 539-50 (2010)
47. M. F. Corsten, R. Miranda, R. Kasmieh, A. M. Krichevsky, R. Weissleder and K. Shah: MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res, 67(19), 8994-9000 (2007) (Pubitemid 47535880)
48. T. Papagiannakopoulos, A. Shapiro and K. S. Kosik: MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res, 68(19), 8164-72 (2008)
49. Y. Li, W. Li, Y. Yang, Y. Lu, C. He, G. Hu, H. Liu, J. Chen, J. He and H. Yu: MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res, 1286, 13-8 (2009)
50. X. Zhou, Y. Ren, L. Moore, M. Mei, Y. You, P. Xu, B. Wang, G. Wang, Z. Jia, P. Pu, W. Zhang and C. Kang: Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest, 90(2), 144-55 (2010)
51. Y. Ren, X. Zhou, M. Mei, X. B. Yuan, L. Han, G. X. Wang, Z. F. Jia, P. Xu, P. Y. Pu and C. S. Kang: MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTENmutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer, 10, 27 (2010)
52. Y. Ren, C. S. Kang, X. B. Yuan, X. Zhou, P. Xu, L. Han, G. X. Wang, Z. Jia, Y. Zhong, S. Yu, J. Sheng and P. Y. Pu: Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro. J Biomater Sci Polym Ed, 21(3), 303-14 (2010)
53. L. Shi, J. Chen, J. Yang, T. Pan, S. Zhang and Z. Wang: MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res, 1352C, 255-264 (2010)
54. Y. Chen, W. Liu, T. Chao, Y. Zhang, X. Yan, Y. Gong, B. Qiang, J. Yuan, M. Sun and X. Peng: MicroRNA-21 downregulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Lett, 272(2), 197-205 (2008)
55. M. Ohno, A. Natsume, Y. Kondo, H. Iwamizu, K. Motomura, H. Toda, M. Ito, T. Kato and T. Wakabayashi: The modulation of microRNAs by type I IFN through the activation of signal transducers and activators of transcription 3 in human glioma. Mol Cancer Res, 7(12), 2022-30 (2009)
56. J. K. Gillies and I. A. Lorimer: Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle, 6(16), 2005-9 (2007) (Pubitemid 47327888)
57. S. A. Ciafre, S. Galardi, A. Mangiola, M. Ferracin, C. G. Liu, G. Sabatino, M. Negrini, G. Maira, C. M. Croce and M. G. Farace: Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun, 334(4), 1351-8 (2005) (Pubitemid 41074723)
58. M. E. Conrad and J. C. Barton: Factors affecting the absorption and excretion of lead in the rat. Gastroenterology, 74(4), 731-40 (1978) (Pubitemid 8333144)
59. O. Slaby, R. Lakomy, P. Fadrus, R. Hrstka, L. Kren, E. Lzicarova, M. Smrcka, M. Svoboda, H. Dolezalova, J. Novakova, D. Valik, R. Vyzula and J. Michalek: MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients. Neoplasma, 57(3), 264-9 (2010)
60. C. Zhang, C. Kang, Y. You, P. Pu, W. Yang, P. Zhao, G. Wang, A. Zhang, Z. Jia, L. Han and H. Jiang: Cosuppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. Int J Oncol, 34(6), 1653-60 (2009)
61. W. J. Lukiw, J. G. Cui, Y. Y. Li and F. Culicchia: Upregulation of micro-RNA-221 (miRNA-221; chr Xp11.3) and caspase-3 accompanies down-regulation of the survivin-1 homolog BIRC1 (NAIP) in glioblastoma multiforme (GBM). J Neurooncol, 91(1), 27-32 (2009)
62. R. Ueda, G. Kohanbash, K. Sasaki, M. Fujita, X. Zhu, E. R. Kastenhuber, H. A. McDonald, D. M. Potter, R. L. Hamilton, M. T. Lotze, S. A. Khan, R. W. Sobol and H. Okada: Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. Proc Natl Acad Sci U S A, 106(26), 10746-51 (2009)
63. C. Zhang, L. Han, A. Zhang, W. Yang, X. Zhou, P. Pu, Y. Du, H. Zeng and C. Kang: Global changes of mRNA expression reveals an increased activity of the interferoninduced signal transducer and activator of transcription (STAT) pathway by repression of miR-221/222 in glioblastoma U251 cells. Int J Oncol, 36(6), 1503-12 (2010)
64. L. Shi, Z. Cheng, J. Zhang, R. Li, P. Zhao, Z. Fu and Y. You: hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res, 1236, 185-93 (2008)
65. G. Chen, W. Zhu, D. Shi, L. Lv, C. Zhang, P. Liu and W. Hu: MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol Rep, 23(4), 997-1003 (2010)
66. J. T. Huse, C. Brennan, D. Hambardzumyan, B. Wee, J. Pena, S. H. Rouhanifard, C. Sohn-Lee, C. le Sage, R. Agami, T. Tuschl and E. C. Holland: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev, 23(11), 1327-37 (2009)
67. H. Kim, W. Huang, X. Jiang, B. Pennicooke, P. J. Park and M. D. Johnson: Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proc Natl Acad Sci U S A, 107(5), 2183-8 (2010)
68. R. Abounader: Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy. Expert Rev Anticancer Ther, 9(2), 235-45 (2009)
69. Y. Li, F. Guessous, C. DiPierro, Y. Zhang, T. Mudrick, L. Fuller, E. Johnson, L. Marcinkiewicz, M. Engelhardt, B. Kefas, D. Schiff, J. Kim and R. Abounader: Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy. Mol Cancer Ther, 8(2), 376-85 (2009)
70. H. Xia, Y. Qi, S. S. Ng, X. Chen, D. Li, S. Chen, R. Ge, S. Jiang, G. Li, Y. Chen, M. L. He, H. F. Kung, L. Lai and M. C. Lin: microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res, 1269, 158-65 (2009)
71. T. Wurdinger, B. A. Tannous, O. Saydam, J. Skog, S. Grau, J. Soutschek, R. Weissleder, X. O. Breakefield and A. M. Krichevsky: miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell, 14(5), 382-93 (2008)
72. H. Xia, Y. Qi, S. S. Ng, X. Chen, S. Chen, M. Fang, D. Li, Y. Zhao, R. Ge, G. Li, Y. Chen, M. L. He, H. F. Kung, L. Lai and M. C. Lin: MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem Biophys Res Commun, 380(2), 205-10 (2009)
73. H. F. Xia, T. Z. He, C. M. Liu, Y. Cui, P. P. Song, X. H. Jin and X. Ma: MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cell Physiol Biochem, 23(4-6), 347-58 (2009)
74. L. Shi, J. Zhang, T. Pan, J. Zhou, W. Gong, N. Liu, Z. Fu and Y. You: MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation. Brain Res, 1312, 120-6 (2010)
75. T. Sasayama, M. Nishihara, T. Kondoh, K. Hosoda and E. Kohmura: MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer, 125(6), 1407-13 (2009)
76. J. Xu, X. Liao and C. Wong: Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. Int J Cancer, 126(4), 1029-35 (2010)
77. Y. Guan, M. Mizoguchi, K. Yoshimoto, N. Hata, T. Shono, S. O. Suzuki, Y. Araki, D. Kuga, A. Nakamizo, T. Amano, X. Ma, K. Hayashi and T. Sasaki: MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. Clin Cancer Res, 16(16), 4289-97 (2010)
78. K. Ujifuku, N. Mitsutake, S. Takakura, M. Matsuse, V. Saenko, K. Suzuki, K. Hayashi, T. Matsuo, K. Kamada, I. Nagata and S. Yamashita: miR-195, miR-455-3p and miR-10a(*) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett, 296(2), 241-8 (2010)
79. S. T. Lee, K. Chu, H. J. Oh, W. S. Im, J. Y. Lim, S. K. Kim, C. K. Park, K. H. Jung, S. K. Lee, M. Kim and J. K. Roh: Let-7 microRNA inhibits the proliferation of human glioblastoma cells. J Neurooncol (2010)
80. L. Jiang, P. Mao, L. Song, J. Wu, J. Huang, C. Lin, J. Yuan, L. Qu, S. Y. Cheng and J. Li: miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol, 177(1), 29-38 (2010)
81. S. A. Rao, V. Santosh and K. Somasundaram: Genomewide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol, 23(10), 1404-17 (2010)
82. B. Kefas, J. Godlewski, L. Comeau, Y. Li, R. Abounader, M. Hawkinson, J. Lee, H. Fine, E. A. Chiocca, S. Lawler and B. Purow: microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res, 68(10), 3566-72 (2008)
83. E. V. Makeyev, J. Zhang, M. A. Carrasco and T. Maniatis: The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative premRNA splicing. Mol Cell, 27(3), 435-48 (2007) (Pubitemid 47126944)
84. H. Gal, G. Pandi, A. A. Kanner, Z. Ram, G. Lithwick-Yanai, N. Amariglio, G. Rechavi and D. Givol: MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochem Biophys Res Commun, 376(1), 86-90 (2008)
85. J. Godlewski, M. O. Nowicki, A. Bronisz, G. Nuovo, J. Palatini, M. De Lay, J. Van Brocklyn, M. C. Ostrowski, E. A. Chiocca and S. E. Lawler: MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell, 37(5), 620-32 (2010)
86. J. Godlewski, M. O. Nowicki, A. Bronisz, S. Williams, A. Otsuki, G. Nuovo, A. Raychaudhury, H. B. Newton, E. A. Chiocca and S. Lawler: Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res, 68(22), 9125-30 (2008)
87. C. A. Fasano, J. T. Dimos, N. B. Ivanova, N. Lowry, I. R. Lemischka and S. Temple: shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC selfrenewal during development. Cell Stem Cell, 1(1), 87-99 (2007) (Pubitemid 46865801)
88. Y. Zhang, T. Chao, R. Li, W. Liu, Y. Chen, X. Yan, Y. Gong, B. Yin, W. Liu, B. Qiang, J. Zhao, J. Yuan and X. Peng: MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med, 87(1), 43-51 (2009)
89. Y. Li, F. Guessous, Y. Zhang, C. Dipierro, B. Kefas, E. Johnson, L. Marcinkiewicz, J. Jiang, Y. Yang, T. D. Schmittgen, B. Lopes, D. Schiff, B. Purow and R. Abounader: MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res, 69(19), 7569-76 (2009)
90. F. Guessous, Y. Zhang, A. Kofman, A. Catania, Y. Li, D. Schiff, B. Purow and R. Abounader: microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle, 9(6) (2010)
91. X. Fan, W. Matsui, L. Khaki, D. Stearns, J. Chun, Y. M. Li and C. G. Eberhart: Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res, 66(15), 7445-52 (2006) (Pubitemid 44289197)
92. A. H. Shih and E. C. Holland: Notch signaling enhances nestin expression in gliomas. Neoplasia, 8(12), 1072-82 (2006) (Pubitemid 44936157)
93. J. Wang, T. P. Wakeman, J. D. Lathia, A. B. Hjelmeland, X. F. Wang, R. R. White, J. N. Rich and B. A. Sullenger: Notch promotes radioresistance of glioma stem cells. Stem Cells, 28(1), 17-28 (2010)
94. X. P. Zhang, G. Zheng, L. Zou, H. L. Liu, L. H. Hou, P. Zhou, D. D. Yin, Q. J. Zheng, L. Liang, S. Z. Zhang, L. Feng, L. B. Yao, A. G. Yang, H. Han and J. Y. Chen: Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol Cell Biochem, 307(1-2), 101-8 (2008) (Pubitemid 350238652)
95. B. Kefas, L. Comeau, D. H. Floyd, O. Seleverstov, J. Godlewski, T. Schmittgen, J. Jiang, C. G. diPierro, Y. Li, E. A. Chiocca, J. Lee, H. Fine, R. Abounader, S. Lawler and B. Purow: The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J Neurosci, 29(48), 15161-8 (2009)
96. A. Ernst, B. Campos, J. Meier, F. Devens, F. Liesenberg, M. Wolter, G. Reifenberger, C. Herold-Mende, P. Lichter and B. Radlwimmer: De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene, 29(23), 3411-22 (2010)
97. I. Lavon, D. Zrihan, A. Granit, O. Einstein, N. Fainstein, M. A. Cohen, M. A. Cohen, B. Zelikovitch, Y. Shoshan, S. Spektor, B. E. Reubinoff, Y. Felig, O. Gerlitz, T. Ben-Hur, Y. Smith and T. Siegal: Gliomas display a microRNA expression profile reminiscent of neural precursor cells. Neuro Oncol, 12(5), 422-33 (2010)